| Shared Decision Making for Antipsychotic Medications (NCT05416658) | New York State Psychiatric Institute | 2027-01-01 |
| An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa (NCT06518941) | New York State Psychiatric Institute | 2027-01-01 |
| Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in Schizophrenia (NCT07715253) | New York State Psychiatric Institute | 2026-12-01 |
| Understanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal Thoughts (NCT07139106) | New York State Psychiatric Institute | 2026-10-01 |
| A Multimodal Imaging Study of Dopamine in Early Psychosis (NCT06977308) | New York State Psychiatric Institute | 2026-10-01 |
| Mindfulness-Based Substance Use Prevention (MINDS-UP) (NCT06593470) | New York State Psychiatric Institute | 2026-10-01 |
| rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder (NCT05974202) | New York State Psychiatric Institute | 2026-08-14 |
| Sleep Interventions and Neurocognitive Outcomes (NCT05987007) | New York State Psychiatric Institute | 2026-08-01 |
| Brief Intervention Addressing Stigma Among Parents of Children With Mental Health Problems (NCT07594730) | New York State Psychiatric Institute | 2026-07-06 |
| Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual (NCT05339256) | New York State Psychiatric Institute | 2026-06-01 |
| Helping Adults With Obsessive-Compulsive Disorder Succeed at Work (NCT07124780) | New York State Psychiatric Institute | 2026-05-12 |
| Dopamine D3 Receptor Occupancy in Bipolar Depression (NCT05060549) | New York State Psychiatric Institute | 2026-01-06 |
| Investigating the Effect of Dronabinol on Post-surgical Pain (NCT04099355) | New York State Psychiatric Institute | 2025-09-01 |
| Exercise and Olanzapine-samidorphan (NCT06740890) | New York State Psychiatric Institute | 2025-06-26 |
| Impacts of Cash Transfers on Child Neurodevelopment (Auxilio Brasil) (NCT05477901) | New York State Psychiatric Institute | 2025-05-28 |
| Treating Common Mental Disorders in Women in Mozambique by Addressing Intimate Partner Violence in Couples (NCT06252909) | New York State Psychiatric Institute | 2025-05-01 |
| RCT of a Brief Video Intervention Targeting Peer Inclusion to Reduce Depression-related Stigma in Adolescents (NCT06360107) | New York State Psychiatric Institute | 2024-12-17 |
| Reducing Stigma and Increasing Treatment Seeking Intentions Among Adolescents (NCT06222528) | New York State Psychiatric Institute | 2024-06-03 |
| Reducing Depression Self-stigma and Increasing Treatment Seeking Intentions Among Youth (NCT06172075) | New York State Psychiatric Institute | 2024-04-15 |
| Using Mobile Technology to Prevent HIV and Related Youth Health Problems (NCT05130151) | New York State Psychiatric Institute | 2023-08-09 |
| Scaling up e-Connect in Juvenile Probation Settings (NCT05541926) | New York State Psychiatric Institute | 2023-05-02 |
| Effects of rTMS on Food Choice in Anorexia Nervosa (NCT05918835) | New York State Psychiatric Institute | 2023-04-24 |
| Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder (NCT05011266) | New York State Psychiatric Institute | 2023-04-18 |
| Tailoring Overdose Education for Black Churches (NCT05645016) | New York State Psychiatric Institute | 2023-04-01 |
| Effectiveness and Cost-Effectiveness of Depression Treatment for Individuals With TB in South Africa (NCT05091580) | New York State Psychiatric Institute | 2023-03-24 |
| Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Sequelae of COVID (PASC): A Pilot Trial (NCT05690503) | New York State Psychiatric Institute | 2023-03-20 |
| Sublingual Dexmedetomidine for Treating Opioid Withdrawal (NCT05712707) | New York State Psychiatric Institute | 2023-02-28 |
| A Study of SPG Block for Opioid Withdrawal (NCT04946656) | New York State Psychiatric Institute | 2023-02-03 |
| Reducing Self-stigma Using Brief Video Intervention (NCT05878470) | New York State Psychiatric Institute | 2023-01-25 |
| Air Pollution and Development in the Boricua Youth Study (NCT05368493) | New York State Psychiatric Institute | 2023-01-23 |
| Investigation of TEST (Transcranial Electric Stimulation Therapy) for Chronic Pain (NCT05113563) | New York State Psychiatric Institute | 2023-01-02 |
| D-serine AudRem: R33 Phase (NCT05046353) | New York State Psychiatric Institute | 2022-12-01 |
| Glutamatergic Mechanisms: Aim2 (NCT05401227) | New York State Psychiatric Institute | 2022-10-15 |
| Anti-suicidal Effects of Buprenorphine In Depressed Individuals (NCT05427981) | New York State Psychiatric Institute | 2022-10-10 |
| Partners in School: Promoting Continuity Across Home and School (NCT05154981) | New York State Psychiatric Institute | 2022-09-15 |
| A Trial of Guanfacine-er for Cannabis Use Disorder (NCT05273567) | New York State Psychiatric Institute | 2022-06-01 |
| Pilot Study Adapting EAT-PTSD for Anxious Youth (NCT05298397) | New York State Psychiatric Institute | 2022-04-29 |
| Scaffolding of Brain Operations (NCT05412901) | New York State Psychiatric Institute | 2022-04-10 |
| Boricua Youth Study COVID-19 Coping Intervention Study (NCT05444881) | New York State Psychiatric Institute | 2022-03-28 |
| Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial (NCT05208190) | New York State Psychiatric Institute | 2022-03-17 |
| Multimodal Assessment of Cannabinoid Target Engagement in Adults With Obsessive-Compulsive Disorder (NCT04880278) | New York State Psychiatric Institute | 2022-03-01 |
| Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer (NCT04973930) | New York State Psychiatric Institute | 2022-03-01 |
| Culturally Centering Medications for Opioid Use Disorder With American Indian and Alaska Native Communities (NCT04958798) | New York State Psychiatric Institute | 2021-12-20 |
| Impact of Telehealth on Engagement in Psychotherapy and/or Medication Treatment (NCT04931927) | New York State Psychiatric Institute | 2021-11-08 |
| Vaped Marijuana to Attenuate Naloxone-Precipitated Withdrawal (NCT05114460) | New York State Psychiatric Institute | 2021-11-01 |
| Levodopa and Exercise for Older Adults With Depression and Psychomotor Slowing (NCT04650217) | New York State Psychiatric Institute | 2021-10-07 |
| Community I-STAR Mozambique: Community Implementation of SBIRT Using Technology for Alcohol Use Reduction in Mozambique (NCT03610815) | New York State Psychiatric Institute | 2021-10-01 |
| Cognitive Functioning in Opioid Use Disorder (NCT05001789) | New York State Psychiatric Institute | 2021-09-21 |
| Impact of Repeatedly-Administered THC-cannabis on Experimental Pain and Abuse Liability in Humans (NCT04596644) | New York State Psychiatric Institute | 2021-08-01 |
| Relapse Prevention and Changing Habits in Anorexia Nervosa (NCT04810624) | New York State Psychiatric Institute | 2021-06-21 |
| Repeated Cannabis Administration on Experimental Pain and Abuse Liability (NCT04576507) | New York State Psychiatric Institute | 2021-06-01 |
| Leveraging Social Networks to Increase COVID-19 Testing Uptake (NCT04873401) | New York State Psychiatric Institute | 2021-04-20 |
| Neuroinflammation in Patients With OCD (NCT04786548) | New York State Psychiatric Institute | 2021-04-01 |
| A Gender-Enhanced Pre-Exposure Prophylaxis (PrEP) Information-Motivational Workshop for Young South African Women (NCT04833127) | New York State Psychiatric Institute | 2021-03-17 |
| Surmounting Withdrawal to Initiate Fast Treatment With Naltrexone (NCT04762537) | New York State Psychiatric Institute | 2021-03-16 |
| Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder (NCT04656301) | New York State Psychiatric Institute | 2021-02-26 |
| Computer - Based Treatment for Social Anxiety Disorder (NCT04663724) | New York State Psychiatric Institute | 2021-02-15 |
| 1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study) (NCT04493320) | New York State Psychiatric Institute | 2021-02-10 |
| IM Ketamine vs Midazolam for Suicidal ER Patients (NCT04640636) | New York State Psychiatric Institute | 2021-02-09 |
| Valacyclovir for Mild Cognitive Impairment (NCT04710030) | New York State Psychiatric Institute | 2021-02-01 |
| Pregabalin Trial for the Treatment of Alcohol Use Disorder (NCT04322305) | New York State Psychiatric Institute | 2021-01-11 |
| Glutamatergic Mechanisms of Psychosis and Target Engagement (SA1) (NCT04589208) | New York State Psychiatric Institute | 2021-01-01 |
| Mechanisms of Emotion Regulation Underlying Successful CBT in Depression (NCT04328103) | New York State Psychiatric Institute | 2020-11-25 |
| Ketamine Treatment Effects on Synaptic Plasticity in Depression (NCT04091971) | New York State Psychiatric Institute | 2020-10-09 |
| Using mHealth to Optimize Pharmacotherapy Regimens (NCT04248517) | New York State Psychiatric Institute | 2020-10-09 |
| Clinical Trials of Multivalent Opioid Vaccine Components (NCT04458545) | New York State Psychiatric Institute | 2020-10-08 |
| Use of Antiretroviral (ARV) Drug Levels in Dried Blood Spots (DBS) to Assess and Manage ART Adherence in South Africa (NCT04333498) | New York State Psychiatric Institute | 2020-09-18 |
| Improving Alcohol Use Disorder Treatment for Gender Minority Populations (NCT05070793) | New York State Psychiatric Institute | 2020-08-01 |
| Facilitating Opioid Care Connections (NCT04216719) | New York State Psychiatric Institute | 2020-03-18 |
| Influence of Tobacco Use on Cannabis Use (NCT03766971) | New York State Psychiatric Institute | 2020-02-01 |
| Anti-suicidal Effects of Buprenorphine in Opioid Use Disorder (NCT04234516) | New York State Psychiatric Institute | 2020-01-20 |
| Suicide Prevention in Prepubertal Children (NCT04171089) | New York State Psychiatric Institute | 2019-12-27 |
| The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking (NCT04084860) | New York State Psychiatric Institute | 2019-11-08 |
| Treating Self Injurious Behavior: A Novel Brain Stimulation Approach (NCT04244786) | New York State Psychiatric Institute | 2019-10-01 |
| Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment (NCT04056182) | New York State Psychiatric Institute | 2019-09-01 |
| Imaging the Effects of rTMS on Chronic Pain (NCT02687360) | New York State Psychiatric Institute | 2019-09-01 |
| Investigation of the NMDA Antagonist Ketamine as a Treatment for Tinnitus (NCT03336398) | New York State Psychiatric Institute | 2019-09-01 |
| OnTrackNY's Learning Healthcare System (NCT04021719) | New York State Psychiatric Institute | 2019-08-15 |
| Lorcaserin for Cannabis Use Disorder (NCT03637842) | New York State Psychiatric Institute | 2019-08-01 |
| IPT-A for Adolescents With PTSD Symptoms (NCT03795818) | New York State Psychiatric Institute | 2019-08-01 |
| The Effect of rTMS to the Prefrontal Cortex in Alcohol Use Disorder (NCT03809286) | New York State Psychiatric Institute | 2019-06-24 |
| Cognitive Remediation for Coordinated Specialty Care (NCT03930251) | New York State Psychiatric Institute | 2019-06-01 |
| A Pilot Study of SPG Block for PTSD (NCT05743543) | New York State Psychiatric Institute | 2019-05-28 |
| Adapting Critical Time Intervention to Support Inpatient Medical Care Transition (NCT03637296) | New York State Psychiatric Institute | 2019-05-01 |
| Effects of Cannabis on Prescription Drug Abuse Liability and Analgesia (NCT03679949) | New York State Psychiatric Institute | 2019-04-01 |
| D-serine Augmentation of Neuroplasticity (NCT03711500) | New York State Psychiatric Institute | 2019-03-13 |
| An Open-Label Pilot Study of Sublocade as Treatment for Opiate Use Disorder (NCT03861338) | New York State Psychiatric Institute | 2019-03-01 |
| ITI-007 (Lumateperone Tosylate) for Schizophrenia (NCT03817528) | New York State Psychiatric Institute | 2019-03-01 |
| Development of Novel Measures for Alzheimer's Disease Prevention Trials (NCT03900273) | New York State Psychiatric Institute | 2019-02-25 |
| 18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar Disorder (NCT03902613) | New York State Psychiatric Institute | 2019-02-07 |
| Contact: Developing New Clinical Management Strategies (NCT03812588) | New York State Psychiatric Institute | 2019-01-30 |
| L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults (NCT03761030) | New York State Psychiatric Institute | 2019-01-09 |
| Training Providers to Conduct PRIDES-sSA (NCT03610750) | New York State Psychiatric Institute | 2018-12-01 |
| Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCV (NCT03652675) | New York State Psychiatric Institute | 2018-11-01 |
| Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals (NCT03711318) | New York State Psychiatric Institute | 2018-11-01 |
| Improving Accessibility and Personalization of CR for Schizophrenia (NCT03576976) | New York State Psychiatric Institute | 2018-07-16 |
| Web-based Addiction Treatment: Cultural Adaptation With American Indians (NCT03363256) | New York State Psychiatric Institute | 2018-05-30 |
| Treating Hearing Loss to Improve Mood and Cognition in Older Adults (NCT03321006) | New York State Psychiatric Institute | 2018-05-30 |
| Glutamate Reducing Interventions in Schizophrenia (NCT03321617) | New York State Psychiatric Institute | 2018-04-17 |
| Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma (NCT03246113) | New York State Psychiatric Institute | 2018-03-19 |